| Market revenue in 2024 | USD 250.6 million |
| Market revenue in 2033 | USD 402.8 million |
| Growth rate | 5.4% (CAGR from 2025 to 2033) |
| Largest segment | Api |
| Fastest growing segment | API |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | API, Drug Product |
| Key market players worldwide | Lonza Group Ltd, Thermo Fisher Scientific Inc, Labcorp Holdings Inc, Catalent Inc, Wuxi AppTec Co Ltd, Siegfried Holding AG, Nipro Corp, Piramal Pharma Solutions, Recipharm Venture Fund, CordenPharma, Cambrex, Bushu Pharmaceuticals, Seqens |
The pharmaceutical CDMO market in Kuwait is growing considerably due to the increasing number of CDMOs, demand for drugs (tablets, capsules, powders, & granules), access to high-value products, capacity to produce innovative drugs locally, and regulatory controls.
Besides, the growing adoption of generic drugs is expected to create opportunities for pharmaceutical CDMOs in Kuwait. In addition, the establishment and expansion of products in the country is another major factor fueling the market growth.
Thus, the increasing number of research activities, pharmaceutical companies, and government support for drug development contribute to market growth.
Publish Date: Sep 15, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Labcorp Holdings Inc | View profile | 67,000 | 358 South Main Street, Burlington, NC, United States, 27215 | www.labcorp.com |
| Nipro Corp | View profile | 39,713 | 3-9-3 Honjo-Nishi Kita-ku, Osaka, Japan, 531-8510 | www.nipro.co.jp |
| Wuxi AppTec Co Ltd | View profile | 41,116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | www.wuxiapptec.com |
| Catalent Inc | View profile | 17,219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | www.catalent.com |
| Siegfried Holding AG | View profile | 4,180 | Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 | www.siegfried.ch |
| Piramal Pharma Solutions | View profile | 1001-5000 | Riverview, Michigan, United States, North America | www.piramalpharmasolutions.com/ |
| CordenPharma | View profile | 5001-10000 | Plankstadt, Baden-Wurttemberg, Germany, Europe | cordenpharma.com |
| Cambrex | View profile | 1001-5000 | East Rutherford, New Jersey, United States, North America | www.cambrex.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Pharmaceutical CDMO Market Outlook will help companies and investors design strategic landscapes.
Api was the largest segment with a revenue share of 80.97% in 2024.
Horizon Databook has segmented the Kuwait pharmaceutical cdmo market based on api, drug product covering the revenue growth of each sub-segment from 2021 to 2033.
The pharmaceutical CDMO market in Kuwait is growing considerably due to the increasing number of CDMOs, demand for drugs (tablets, capsules, powders, & granules), access to high-value products, capacity to produce innovative drugs locally, and regulatory controls.
Besides, the growing adoption of generic drugs is expected to create opportunities for pharmaceutical CDMOs in Kuwait. In addition, the establishment and expansion of products in the country is another major factor fueling the market growth.
Thus, the increasing number of research activities, pharmaceutical companies, and government support for drug development contribute to market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait Pharmaceutical CDMO Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Kuwait Pharmaceutical CDMO Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
